Crinetics Pharmaceuticals Inc. CRNX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small-molecule therapeutics for rare endocrine diseases and endocrine-related tumors. Its proprietary platform targets key hormone receptor signaling pathways, including som…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees437
TickerCRNX
Statistics
Market Cap$3.74B
Revenue (TTM)$7.7M
Net Income-$465.3M
Net Margin-6046.2%
EPS$-4.95
P/E-6.77
P/S204.06
P/B2.88
EV/EBITDA-4.51
ROE-39.2%
Dividend Yield—
Price$35.48
Data: Twelve Data · Revenue = mcap / P/S